Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-029306
Filing Date
2024-12-13
Accepted
2024-12-13 16:26:12
Documents
1
Period of Report
2024-12-12

Document Format Files

Seq Description Document Type Size
1 form4-12132024_091209.html 4  
1 form4-12132024_091209.xml 4 4143
  Complete submission text file 0001415889-24-029306.txt   5830
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 WELLESLEY WAY FREEHOLD NJ 07728
Business Address
Guarino Jonathan L. (Reporting) CIK: 0001787282 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14778 | Film No.: 241548772